1687 related articles for article (PubMed ID: 17361370)
1. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
3. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.
Tonegutti M; Girardi V
Radiol Med; 2008 Feb; 113(1):65-75. PubMed ID: 18338128
[TBL] [Abstract][Full Text] [Related]
5. [Stereotactic vacuum core biopsy of clustered microcalcifications classified as B1-RADS 3].
Obenauer S; Fischer U; Baum F; Dammert S; Füzesi L; Grabbe E
Rofo; 2001 Aug; 173(8):696-701. PubMed ID: 11570238
[TBL] [Abstract][Full Text] [Related]
6. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M
Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
[TBL] [Abstract][Full Text] [Related]
7. The value of dynamic contrast enhanced breast MRI in mammographically detected BI-RADS 5 microcalcifications.
Houserkova D; Prasad SN; Svach I; Kucerova L; Duskova M; Bucil J; Sisola I; Zlamalova N; Svebisova H
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):107-15. PubMed ID: 18795084
[TBL] [Abstract][Full Text] [Related]
8. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
9. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
Li E; Li J; Song Y; Xue M; Zhou C
PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
Bazzocchi M; Zuiani C; Panizza P; Del Frate C; Soldano F; Isola M; Sardanelli F; Giuseppetti GM; Simonetti G; Lattanzio V; Del Maschio A
AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
[TBL] [Abstract][Full Text] [Related]
14. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA
Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279
[TBL] [Abstract][Full Text] [Related]
15. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
19. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P
Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of high-resolution MRI using a microscopy coil for patients with presumed DCIS following mammography screening.
Zhu J; Kurihara Y; Kanemaki Y; Ogata H; Fukuda M; Nakajima Y; Maeda I
J Magn Reson Imaging; 2007 Jan; 25(1):96-103. PubMed ID: 17154376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
